# Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions

> **NCT02633384** · PHASE4 · TERMINATED · sponsor: **Centro Hospitalar de Lisboa Central** · enrollment: 52 (actual)

## Conditions studied

- Intrahepatic, Cholestasis

## Interventions

- **OTHER:** SMOFlipid
- **OTHER:** Lipofundin

## Key facts

- **NCT ID:** NCT02633384
- **Lead sponsor:** Centro Hospitalar de Lisboa Central
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2015-07
- **Final completion:** 2017-04
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** One of the intravenous lipid emulsions was retired from the market
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633384, "Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02633384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*